Commonly used blood pressure medications are safe for COVID-19 patients Commonly used blood pressure medications are safe for COVID-19 patients A Penn Medicine-led trial found medications to be neither beneficial or harmful in the treatment of hospitalized patients.
Penn Dining spring 2021: Four takeaways Penn Dining spring 2021: Four takeaways As students return to campus, dining services has adopted measures to support new safety and public health protocols at both residential and retail cafés on campus.
A how-to guide for COVID-19 testing at Penn A how-to guide for COVID-19 testing at Penn With the launch of Penn Cares, Penn Today provides additional details on the new testing program, how eligible members of the Penn community can enroll, and how the testing procedure works.
Study suggests Pfizer vaccine works against virus variant Penn In the News The Washington Post Study suggests Pfizer vaccine works against virus variant Frederic Bushman of the Perelman School of Medicine said there’s no reason to think the COVID-19 vaccines won’t work on new strains of the virus. “A mutation will change one little place, but it’s not going to disrupt binding to all of them,” he said. How can the world allocate COVID-19 vaccines fairly? How can the world allocate COVID-19 vaccines fairly? It’s an ethical question many Penn experts are contemplating. One fact is certain, they say: Distribution must not exacerbate disparities and inequities in health care. Could cutting or delaying doses of the COVID-19 vaccine to immunize more people make the pandemic last longer? Penn In the News Philadelphia Inquirer Could cutting or delaying doses of the COVID-19 vaccine to immunize more people make the pandemic last longer? Steven Joffe of the Perelman School of Medicine commented on the unknown efficacy of a single dose of the COVID-19 vaccine, which was designed to be given in two doses. “Those unknowns are why some people say, ‘We should stick with what we know. By all means, do the trials to test [varied regimens], but don’t just wing it.’ Others say, ‘We are in a race against the virus.’ I’m not going to come down on one side or the other,” he said. Move-In spring 2021 primer Move-In spring 2021 primer With undergraduate Move-in starting Jan. 10, Penn Today offers a practical guide to the process. Study: One dose of vaccine may be enough for people who had COVID-19 Penn In the News The Hill Study: One dose of vaccine may be enough for people who had COVID-19 E. John Wherry of the Perelman School of Medicine expressed skepticism about assertions that coronavirus survivors may not need a second dose of the vaccine because they already have antibodies. “Just because an antibody binds to a part of the virus does not mean it’s going to protect you from being infected,” he said. Even for people with severe allergies, the COVID-19 vaccine could be a wise decision, experts say Penn In the News Philadelphia Inquirer Even for people with severe allergies, the COVID-19 vaccine could be a wise decision, experts say Pablo Tebas of the Perelman School of Medicine said that in spite of some reports of allergic reactions to the COVID-19 vaccine, the rareness of these events makes it still worth pursuing vaccination. With patients dying daily, “the risk of [getting the vaccine] in a controlled environment is much less, orders of magnitude less, than getting COVID,” he said. Will coronavirus vaccines work against new variant? UPenn doctor weighs in Penn In the News 6ABC.com Will coronavirus vaccines work against new variant? UPenn doctor weighs in Susan Weiss of the Perelman School of Medicine said the COVID-19 vaccine should still be effective on new mutations of the novel coronavirus, a theory vaccine-makers are testing now. "It's a good thing to do but I am sure they're pretty confident it's not going to show anything different," she said. Load More
How can the world allocate COVID-19 vaccines fairly? How can the world allocate COVID-19 vaccines fairly? It’s an ethical question many Penn experts are contemplating. One fact is certain, they say: Distribution must not exacerbate disparities and inequities in health care.
Could cutting or delaying doses of the COVID-19 vaccine to immunize more people make the pandemic last longer? Penn In the News Philadelphia Inquirer Could cutting or delaying doses of the COVID-19 vaccine to immunize more people make the pandemic last longer? Steven Joffe of the Perelman School of Medicine commented on the unknown efficacy of a single dose of the COVID-19 vaccine, which was designed to be given in two doses. “Those unknowns are why some people say, ‘We should stick with what we know. By all means, do the trials to test [varied regimens], but don’t just wing it.’ Others say, ‘We are in a race against the virus.’ I’m not going to come down on one side or the other,” he said. Move-In spring 2021 primer Move-In spring 2021 primer With undergraduate Move-in starting Jan. 10, Penn Today offers a practical guide to the process. Study: One dose of vaccine may be enough for people who had COVID-19 Penn In the News The Hill Study: One dose of vaccine may be enough for people who had COVID-19 E. John Wherry of the Perelman School of Medicine expressed skepticism about assertions that coronavirus survivors may not need a second dose of the vaccine because they already have antibodies. “Just because an antibody binds to a part of the virus does not mean it’s going to protect you from being infected,” he said. Even for people with severe allergies, the COVID-19 vaccine could be a wise decision, experts say Penn In the News Philadelphia Inquirer Even for people with severe allergies, the COVID-19 vaccine could be a wise decision, experts say Pablo Tebas of the Perelman School of Medicine said that in spite of some reports of allergic reactions to the COVID-19 vaccine, the rareness of these events makes it still worth pursuing vaccination. With patients dying daily, “the risk of [getting the vaccine] in a controlled environment is much less, orders of magnitude less, than getting COVID,” he said. Will coronavirus vaccines work against new variant? UPenn doctor weighs in Penn In the News 6ABC.com Will coronavirus vaccines work against new variant? UPenn doctor weighs in Susan Weiss of the Perelman School of Medicine said the COVID-19 vaccine should still be effective on new mutations of the novel coronavirus, a theory vaccine-makers are testing now. "It's a good thing to do but I am sure they're pretty confident it's not going to show anything different," she said. Load More
Move-In spring 2021 primer Move-In spring 2021 primer With undergraduate Move-in starting Jan. 10, Penn Today offers a practical guide to the process.
Study: One dose of vaccine may be enough for people who had COVID-19 Penn In the News The Hill Study: One dose of vaccine may be enough for people who had COVID-19 E. John Wherry of the Perelman School of Medicine expressed skepticism about assertions that coronavirus survivors may not need a second dose of the vaccine because they already have antibodies. “Just because an antibody binds to a part of the virus does not mean it’s going to protect you from being infected,” he said. Even for people with severe allergies, the COVID-19 vaccine could be a wise decision, experts say Penn In the News Philadelphia Inquirer Even for people with severe allergies, the COVID-19 vaccine could be a wise decision, experts say Pablo Tebas of the Perelman School of Medicine said that in spite of some reports of allergic reactions to the COVID-19 vaccine, the rareness of these events makes it still worth pursuing vaccination. With patients dying daily, “the risk of [getting the vaccine] in a controlled environment is much less, orders of magnitude less, than getting COVID,” he said. Will coronavirus vaccines work against new variant? UPenn doctor weighs in Penn In the News 6ABC.com Will coronavirus vaccines work against new variant? UPenn doctor weighs in Susan Weiss of the Perelman School of Medicine said the COVID-19 vaccine should still be effective on new mutations of the novel coronavirus, a theory vaccine-makers are testing now. "It's a good thing to do but I am sure they're pretty confident it's not going to show anything different," she said. Load More
Even for people with severe allergies, the COVID-19 vaccine could be a wise decision, experts say Penn In the News Philadelphia Inquirer Even for people with severe allergies, the COVID-19 vaccine could be a wise decision, experts say Pablo Tebas of the Perelman School of Medicine said that in spite of some reports of allergic reactions to the COVID-19 vaccine, the rareness of these events makes it still worth pursuing vaccination. With patients dying daily, “the risk of [getting the vaccine] in a controlled environment is much less, orders of magnitude less, than getting COVID,” he said. Will coronavirus vaccines work against new variant? UPenn doctor weighs in Penn In the News 6ABC.com Will coronavirus vaccines work against new variant? UPenn doctor weighs in Susan Weiss of the Perelman School of Medicine said the COVID-19 vaccine should still be effective on new mutations of the novel coronavirus, a theory vaccine-makers are testing now. "It's a good thing to do but I am sure they're pretty confident it's not going to show anything different," she said. Load More
Will coronavirus vaccines work against new variant? UPenn doctor weighs in Penn In the News 6ABC.com Will coronavirus vaccines work against new variant? UPenn doctor weighs in Susan Weiss of the Perelman School of Medicine said the COVID-19 vaccine should still be effective on new mutations of the novel coronavirus, a theory vaccine-makers are testing now. "It's a good thing to do but I am sure they're pretty confident it's not going to show anything different," she said.